Cyclooxygenase-2 expression in the barrett's metaplasia-dysplasia-adenocarcinoma sequence

American Journal of Gastroenterology

Volumn 96, Issue 4, 2001, Pages 990-996

  Morris, Clive D ^b   Armstrong, Gordon R ^b   Bigley, Graham ^b   Green, Helen ^b   Attwood, Stephen E A ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; BENIGN TUMOR; CARCINOGENESIS; COLON CARCINOMA; DISEASE COURSE; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CYCLOOXYGENASE 2; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; METAPLASIA; PEROXIDASES; PRECANCEROUS CONDITIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RETROSPECTIVE STUDIES;

EID: 0035045145     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02392-3     Document Type: Article

References (25)

1. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
2. The epidemiology of adenocarcinoma of the oesophagus and gastric cardia in the North West of England
3. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value?
4. Changing patterns and surgical results in adenocarcinoma of the oesophagus
5. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
6. Aspirin and reduced risk of esophageal carcinoma
7. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts
8. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function
9. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
10. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
11. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
12. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
13. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
14. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
15. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
16. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
17. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
18. Cyclooxygenase-2 expression in human esophageal carcinoma
19. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
20. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
21. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
22. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifferentiation
23. Cyclooxygenase-2 over-expression enhances lymphatic invasion and metastasis in human gastric carcinoma
24. Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc
25. Dihydroxy bile acids activate the transcription of cyclooxygenase-2